Aligos Therapeutics (ALGS) Other Accumulated Expenses (2019 - 2026)
Aligos Therapeutics' Other Accumulated Expenses came in at $7.03 million for Q2 2026, up 83.8% from $3.82 million a year earlier and up 65.2% from the prior quarter.
Powered by 
Analysis
Aligos Therapeutics (ALGS) Other Accumulated Expenses (2019 - 2026) Analysis & Trends
At the end of FY2025, Aligos Therapeutics' Other Accumulated Expenses was $3.25 million, down 39.6% from FY2024.
- Other Accumulated Expenses carries a five-year compound annual growth rate of 81.1% (FY2020 to FY2025).
- Going back by year, Other Accumulated Expenses was $5.38 million in FY2024 (-18.9%), $6.63 million in FY2023 (+350.3%), $1.47 million in FY2022 (+19.3%) and $1.24 million in FY2021 (+639.5%).
- The Q2 2026 figure represents the highest quarterly Other Accumulated Expenses in data going back to Q4 2019.
- Year-over-year, Other Accumulated Expenses increased in six of the last eight quarters, with growth averaging 38.3%.
- The fastest year-over-year change in Other Accumulated Expenses over five years came in Q4 2021 (growth of 639.5%), and the weakest in Q4 2025 (a decline of 39.6%).
- Business Quant data shows ALGS's Other Accumulated Expenses at $4.26 million (Q1 2026), $3.25 million (Q4 2025) and $4.83 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Aligos Therapeutics | 50.28 Mn | -278.13 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.03 Mn |
| Mar 31, 2026 | 4.26 Mn |
| Dec 31, 2025 | 3.25 Mn |
| Sep 30, 2025 | 4.83 Mn |
| Jun 30, 2025 | 3.82 Mn |
| Mar 31, 2025 | 3.85 Mn |
| Dec 31, 2024 | 5.38 Mn |
| Sep 30, 2024 | 2.75 Mn |
| Jun 30, 2024 | 2.71 Mn |
| Mar 31, 2024 | 2.84 Mn |
| Dec 31, 2023 | 6.63 Mn |
| Sep 30, 2023 | 1.26 Mn |
| Jun 30, 2023 | 1.44 Mn |
| Mar 31, 2023 | 2.27 Mn |
| Dec 31, 2022 | 1.47 Mn |
| Sep 30, 2022 | 912,000.00 |
| Jun 30, 2022 | 856,000.00 |
| Mar 31, 2022 | 1.14 Mn |
| Dec 31, 2021 | 1.24 Mn |
| Sep 30, 2021 | 1.07 Mn |
API Access
Aligos Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ALGS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();